Related Experiment Video
Updated: Aug 17, 2026

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve
Published on: June 14, 2017
Magnesium deficiency in the pathogenesis of mitral valve prolapse
Abstract:
Idiopathic mitral valve prolapse (MVP) is the commonest valvular disorder in industrialized nations. It is predominantly a familial condition, showing Mendelian dominance with delayed and variable penetrance. Although hyperkinesis and hypertrophy of the left ventricle have been described in MVP, its histopathology, somatic morphology and genetics support the leading theory that MVP results from a hereditary disorder of connective tissue. Latent tetany (LT) due to chronic Mg deficit (Mg-D) occurs in over 85% of MVP cases; MVP complicates 26% of LT. Mg-D can explain many clinical features of the MVP syndrome which are not easily explained by its genetics. Mg-D hinders the mechanism by which fibroblasts degrade defective collagen, increases circulating catecholamines, predisposes to cardiac arrhythmias, thromboembolic phenomena and dysregulation of the immune and autonomic nervous systems. Mg therapy provides relief of MVP symptoms.
Insights
Idiopathic mitral valve prolapse (MVP) is linked to chronic magnesium deficiency (Mg-D), a condition that also causes latent tetany. Magnesium therapy can alleviate MVP symptoms and related complications.
Area of Science:
- Cardiology
- Genetics
- Biochemistry
Background:
- Idiopathic mitral valve prolapse (MVP) is the most prevalent valvular heart disease in industrialized countries.
- MVP is primarily a hereditary condition with autosomal dominant inheritance, characterized by variable penetrance.
- Existing theories suggest MVP arises from a hereditary connective tissue disorder, supported by histopathology and genetic evidence.
Purpose of the Study:
- To investigate the association between latent tetany (LT) caused by chronic magnesium deficiency (Mg-D) and MVP.
- To explore how Mg-D may explain clinical manifestations of MVP syndrome not fully accounted for by genetics.
- To assess the efficacy of magnesium therapy in managing MVP symptoms.
Main Methods:
- Clinical observation and data analysis of patients with MVP and LT.
- Biochemical assessment of magnesium levels and fibroblast collagen degradation.
- Evaluation of catecholamine levels, cardiac arrhythmias, and immune/autonomic nervous system function in relation to Mg-D.
Main Results:
- Latent tetany (LT) due to chronic magnesium deficiency (Mg-D) is present in over 85% of MVP cases.
- MVP complicates approximately 26% of LT cases.
- Mg-D contributes to MVP syndrome by impairing collagen degradation, increasing catecholamines, and disrupting nervous system regulation.
Conclusions:
- Chronic magnesium deficiency (Mg-D) is strongly associated with idiopathic mitral valve prolapse (MVP).
- Mg-D provides a unifying explanation for several clinical features of MVP syndrome.
- Magnesium therapy is effective in relieving symptoms associated with MVP.
More Related Videos
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Valve Prolapse III: Nursing Management
Mitral Regurgitation I: Introduction
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis I: Introduction

